Literature DB >> 2313302

Some clinical and pathologic observations on chronic myelopathy: a variant of multiple sclerosis.

B G Weinshenker1, J J Gilbert, G C Ebers.   

Abstract

Four patients with progressive demyelinating myelopathy with symptoms spanning six to 25 years are described. There was no clinical evidence of dissemination of lesions in the central nervous system. Radiological evidence of dissemination was present in two cases; in one this was absent at the time of presentation and was only demonstrated after six years of progressive unifocal disease. In one case, pathological examination revealed a solitary area of chronic demyelination. In all cases but one, oligoclonal bands were detected on cerebrospinal fluid (CSF) electrophoresis. Some cases of chronically progressive myelopathy result from focal demyelination in the absence of a second lesion demonstrable by clinical, radiographic or necropsy examination.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2313302      PMCID: PMC487956          DOI: 10.1136/jnnp.53.2.146

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  7 in total

1.  MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT.

Authors:  D W Paty; J J Oger; L F Kastrukoff; S A Hashimoto; J P Hooge; A A Eisen; K A Eisen; S J Purves; M D Low; V Brandejs
Journal:  Neurology       Date:  1988-02       Impact factor: 9.910

2.  Magnetic resonance imaging in isolated noncompressive spinal cord syndromes.

Authors:  D H Miller; W I McDonald; L D Blumhardt; G H du Boulay; A M Halliday; G Johnson; B E Kendall; D P Kingsley; D G MacManus; I F Moseley
Journal:  Ann Neurol       Date:  1987-12       Impact factor: 10.422

3.  Leuko-araiosis.

Authors:  V C Hachinski; P Potter; H Merskey
Journal:  Arch Neurol       Date:  1987-01

4.  New diagnostic criteria for multiple sclerosis: guidelines for research protocols.

Authors:  C M Poser; D W Paty; L Scheinberg; W I McDonald; F A Davis; G C Ebers; K P Johnson; W A Sibley; D H Silberberg; W W Tourtellotte
Journal:  Ann Neurol       Date:  1983-03       Impact factor: 10.422

5.  Chronic progressive myelopathy: investigation with CSF electrophoresis, evoked potentials, and CT scan.

Authors:  D W Paty; W T Blume; W F Brown; N Jaatoul; A Kertesz; W McInnis
Journal:  Ann Neurol       Date:  1979-11       Impact factor: 10.422

6.  Osmotic demyelination syndrome following correction of hyponatremia.

Authors:  R H Sterns; J E Riggs; S S Schochet
Journal:  N Engl J Med       Date:  1986-06-12       Impact factor: 91.245

7.  Cranial magnetic resonance imaging in the evaluation of myelopathy of undetermined etiology.

Authors:  R M Miska; K W Pojunas; M P McQuillen
Journal:  Neurology       Date:  1987-05       Impact factor: 9.910

  7 in total
  4 in total

1.  Progressive solitary sclerosis: Gradual motor impairment from a single CNS demyelinating lesion.

Authors:  B Mark Keegan; Timothy J Kaufmann; Brian G Weinshenker; Orhun H Kantarci; William F Schmalstieg; M Mateo Paz Soldan; Eoin P Flanagan
Journal:  Neurology       Date:  2016-09-16       Impact factor: 9.910

2.  Evolving expectations around early management of multiple sclerosis.

Authors:  Ralf Gold; Jerry S Wolinsky; Maria Pia Amato; Giancarlo Comi
Journal:  Ther Adv Neurol Disord       Date:  2010-11       Impact factor: 6.570

3.  Multiple lesions in cerebral white matter in two young adults with thoracic extramedullary tumours.

Authors:  F Salvi; M Mascalchi; R Plasmati; R Michelucci; F Calbucci; G Dal Pozzo; C A Tassinari
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

4.  Differential diagnosis of suspected multiple sclerosis: a consensus approach.

Authors:  D H Miller; B G Weinshenker; M Filippi; B L Banwell; J A Cohen; M S Freedman; S L Galetta; M Hutchinson; R T Johnson; L Kappos; J Kira; F D Lublin; H F McFarland; X Montalban; H Panitch; J R Richert; S C Reingold; C H Polman
Journal:  Mult Scler       Date:  2008-09-19       Impact factor: 6.312

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.